1상모집 예정
A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
연구 개요
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.
- 스폰서
- 리드: 머크(MSD)
- 적응증
- Healthy
- 중재
- MK-1403 formulation (FM) 1 + additive, MK-1403 FM2 + additive
- 목표 등록
- 15명
- 시작일
- 2026-07-29
- 완료(예정)
- 2026-09-22
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.